Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.289
-0.009 (-2.89%)
At close: Mar 6, 2026, 4:00 PM EST
0.289
0.00 (0.01%)
After-hours: Mar 6, 2026, 7:59 PM EST
Plus Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Plus Therapeutics stock have an average target of 6.75, with a low estimate of 1.00 and a high estimate of 19. The average target predicts an increase of 2,238.07% from the current stock price of 0.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 23, 2026.
Analyst Ratings
The average analyst rating for Plus Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $1 | Strong Buy | Maintains | $2 → $1 | +246.38% | Jan 23, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +1,285.52% | Jan 22, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,631.90% | Jan 8, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,631.90% | Dec 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,631.90% | Dec 1, 2025 |
Financial Forecast
Revenue This Year
5.43M
from 5.82M
Decreased by -6.77%
Revenue Next Year
7.94M
from 5.43M
Increased by 46.30%
EPS This Year
-0.25
from -2.34
EPS Next Year
-0.17
from -0.25
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.8M | 16.4M | ||||
| Avg | 5.4M | 7.9M | ||||
| Low | 5.1M | 3.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.3% | 201.7% | ||||
| Avg | -6.8% | 46.3% | ||||
| Low | -12.5% | -27.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.19 | -0.14 | ||||
| Avg | -0.25 | -0.17 | ||||
| Low | -0.29 | -0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.